Novobiocin
Novobiocin is an antibiotic that is derived from the Streptomyces genus of Actinobacteria. It is classified as an aminocoumarin antibiotic and is primarily used in the treatment of Gram-positive bacteria infections. Novobiocin works by inhibiting the DNA gyrase enzyme, which is essential for bacterial DNA replication.
History[edit]
Novobiocin was first isolated in 1955 from the Streptomyces spheroides strain of Actinobacteria. It was initially used as a broad-spectrum antibiotic, but its use has since been limited due to the development of drug resistance and the availability of safer alternatives.
Mechanism of Action[edit]
Novobiocin's primary mechanism of action is the inhibition of the DNA gyrase enzyme. This enzyme is responsible for introducing negative supercoils into DNA, which is necessary for DNA replication and transcription. By inhibiting this enzyme, Novobiocin prevents bacterial DNA replication, thereby inhibiting bacterial growth and proliferation.
Clinical Use[edit]
Novobiocin is primarily used in the treatment of infections caused by Gram-positive bacteria, including Staphylococcus and Streptococcus species. It is also used in the treatment of infections caused by certain Gram-negative bacteria, such as Haemophilus influenzae.
Side Effects[edit]
Like all antibiotics, Novobiocin can cause side effects. The most common side effects include nausea, vomiting, and diarrhea. Less common side effects can include rash, fever, and anemia. In rare cases, Novobiocin can cause serious side effects such as hepatotoxicity and nephrotoxicity.
Resistance[edit]
Resistance to Novobiocin can occur through several mechanisms. The most common mechanism is the modification of the DNA gyrase enzyme, which reduces the binding affinity of Novobiocin. Other mechanisms of resistance include the efflux of Novobiocin out of the bacterial cell and the production of enzymes that inactivate Novobiocin.
See Also[edit]
| DNA replication (comparing prokaryotic to eukaryotic) | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Sponsored Health Resource
W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
